Back to Investors
RR

RPMI Railpen

Other

RPMI Railpen acts as a long-term investor supporting pioneering companies in the sequencing space.

Portfolio

2

companies


Portfolio companies

CS

CMR Surgical

CMR Surgical manufactures the Versius system for robotic minimal access surgery.

Oxford Nanopore Technologies

Oxford Nanopore Technologies

Oxford Nanopore Technologies develops DNA and RNA sequencing systems for scientific research and public health.


Team

JD

Julia Diez

Portfolio Manager

Julia is a chartered accountant and Head of UK Productive Assets at Railpen, where she previously spent eight years as a portfolio manager covering global equities. She also holds board positions at Gousto, TransferMate Global Payments, and Hulme Grammar School.

LinkedIn

Recent investments

£133M

The upsized funding round was led by existing backers including Ally Bridge Group and Lightrock.

"Versius is very well suited to our needs as a world-leading thoracic surgery department. We have successfully helped patients get the benefit of robotic assisted surgery and we look forward to developing our robotics programme working with CMR and other centres around the world as the adoption of Versius continues."
— Adam Peryt
Series D+
£425M

The funding round was led by SoftBank Vision Fund 2 and co-led by Ally Bridge Group to support international expansion and technological development.

"This latest financing equips CMR with significant funds to accelerate our mission of bringing Versius to hospitals worldwide, whilst providing full flexibility to achieve our goals. This major injection of capital that now values us at $3billion not only reflects the level of interest we have seen in our product, but also the scale of the business, and will enable significant technology developments and global expansion. As the lead investor, SoftBank has a wealth of experience supporting disruptive business models and innovative technologies, and we look forward to leveraging their expertise and extensive ecosystem. I would also like to thank our existing investors for their long-term support."
— Per Vegard Nerseth, Chief Executive Officer